Literature DB >> 19127340

Malondialdehyde, glutathione, and nitric oxide levels in Toxoplasma gondii seropositive patients.

Ulku Karaman1, Tuncay Celik, Tugba Raika Kiran, Cemil Colak, Nilgun Ulfet Daldal.   

Abstract

The aim of this study was to investigate the difference in the serum malondialdehyde (MDA), glutathione (GSH), and nitric oxide (NO) levels between normal and T. gondii-infected patients. To this end, MDA, GSH, and NO levels in the sera of 37 seropositive patients and 40 participants in the control group were evaluated. In Toxoplasma ELISA, IgG results of the patient group were 1,013.0 +/- 543.8 in optical density (mean +/- SD). A statistically significant difference was found between patients and the control group in terms of MDA, GSH, and NO levels. A decrease in GSH activity was detected, while MDA and NO levels increased significantly. Consequently, it is suggested that the use of antioxidant vitamins in addition to a parasite treatment shall prove useful. The high infection vs control ratio of MDA and NO levels probably suggests the occurrence as a mechanism of tissue damage in cases of chronic toxoplasmosis. Moreover, it is recommended that the patient levels of MDA, GSH, and NO should be evaluated in toxoplasmosis.

Entities:  

Keywords:  Toxoplasma gondii; glutathione; malondialdehyde; nitric oxide

Mesh:

Substances:

Year:  2008        PMID: 19127340      PMCID: PMC2612619          DOI: 10.3347/kjp.2008.46.4.293

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  12 in total

1.  Serum malondialdehyde levels in toxoplasma seropositive patients.

Authors:  Sã Leyman Yazar; Eser Kilic; Recep Saraymen; Izzet Sahin
Journal:  Ann Saudi Med       Date:  2003 Nov-Dec       Impact factor: 1.526

2.  Serum malondialdehyde level in patients with cystic echinococcosis.

Authors:  Ismail S Koltas; Guzide Yucebilgic; Ramazan Bilgin; Cem K Parsak; Gurhan Sakman
Journal:  Saudi Med J       Date:  2006-11       Impact factor: 1.484

3.  Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors.

Authors:  Y Nishikawa; O Kawase; O Vielemeyer; H Suzuki; K A Joiner; X Xuan; H Nagasawa
Journal:  Parasite Immunol       Date:  2007-07       Impact factor: 2.280

4.  Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii.

Authors:  Ki-Man Kang; Gye-Sung Lee; Jae-Ho Lee; In-Wook Choi; Dae-Whan Shin; Young-Ha Lee
Journal:  Korean J Parasitol       Date:  2004-12       Impact factor: 1.341

5.  Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production.

Authors:  W Däubener; V Posdziech; U Hadding; C R MacKenzie
Journal:  Med Microbiol Immunol       Date:  1999-03       Impact factor: 3.402

Review 6.  The metabolic coupling of arginine metabolism to nitric oxide generation by astrocytes.

Authors:  Joann M Gensert; Rajiv R Ratan
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

7.  Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.

Authors:  M Mihara; M Uchiyama
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

Review 8.  Incidence, clinical spectrum, and outcome of intrauterine infections in neonates.

Authors:  A K Deorari; S Broor; R S Maitreyi; D Agarwal; H Kumar; V K Paul; M Singh
Journal:  J Trop Pediatr       Date:  2000-06       Impact factor: 1.165

9.  The antioxidant systems in Toxoplasma gondii and the role of cytosolic catalase in defence against oxidative injury.

Authors:  Martina Ding; Lai Yu Kwok; Dirk Schlüter; Christine Clayton; Dominique Soldati
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

10.  Serum malondialdehyde levels in patients infected with Plasmodium vivax.

Authors:  S Yazar; E Kilic; R Saraymen; H Ozbilge
Journal:  West Indian Med J       Date:  2004-06       Impact factor: 0.171

View more
  13 in total

1.  Modulation of immunity in mice with latent toxoplasmosis--the experimental support for the immunosuppression hypothesis of Toxoplasma-induced changes in reproduction of mice and humans.

Authors:  Sárka Kaňková; Vladimír Holáň; Alena Zajícová; Petr Kodym; Jaroslav Flegr
Journal:  Parasitol Res       Date:  2010-08-19       Impact factor: 2.289

Review 2.  Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment.

Authors:  Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Richard G Pestell; Herbert B Tanowitz; Federica Sotgia; Michael P Lisanti
Journal:  Int J Biochem Cell Biol       Date:  2011-02-15       Impact factor: 5.085

3.  Role of oxidative stress in the pathophysiology of Toxoplasma gondii infection.

Authors:  Gungor Cagdas Dincel; Hasan Tarik Atmaca
Journal:  Int J Immunopathol Pharmacol       Date:  2016-03-10       Impact factor: 3.219

4.  Endothelial dysfunction in acute acquired toxoplasmosis.

Authors:  Azhar H Al-Kuraishi; Salah D Al-Windy; Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  Trop Parasitol       Date:  2020-05-20

5.  Effect of Nigella sativa oil on experimental toxoplasmosis.

Authors:  Rasha F Mady; Wessam El-Hadidy; Samar Elachy
Journal:  Parasitol Res       Date:  2015-10-07       Impact factor: 2.289

6.  Oxidative stress and tryptophan degradation pattern of acute Toxoplasma gondii infection in mice.

Authors:  Ayse Basak Engin; Funda Dogruman-Al; Ugur Ercin; Bekir Celebi; Cahit Babur; Neslihan Bukan
Journal:  Parasitol Res       Date:  2012-07-12       Impact factor: 2.289

7.  Extracts of Tectona grandis and Vernonia amygdalina have anti-Toxoplasma and pro-inflammatory properties in vitro.

Authors:  Mlatovi Dégbé; Françoise Debierre-Grockiego; Amivi Tété-Bénissan; Héloïse Débare; Kodjo Aklikokou; Isabelle Dimier-Poisson; Messanvi Gbeassor
Journal:  Parasite       Date:  2018-03-13       Impact factor: 3.000

Review 8.  Oxidative Stress as a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities.

Authors:  Karolina Szewczyk-Golec; Marta Pawłowska; Roland Wesołowski; Marcin Wróblewski; Celestyna Mila-Kierzenkowska
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

9.  Evaluation of the anti-Toxoplasma gondii Activity of Hederagenin in vitro and in vivo.

Authors:  Run-Hui Zhang; Runhao Jin; Hao Deng; Qing-Kun Shen; Zhe-Shan Quan; Chun-Mei Jin
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

10.  In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis.

Authors:  Seon-Ju Yeo; ChunMei Jin; SungYeon Kim; Hyun Park
Journal:  Korean J Parasitol       Date:  2016-04-30       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.